|
1
|
Achen MG, Mann GB and Stacker SA:
Targeting lymphangiogenesis to prevent tumour metastasis. Br J
Cancer. 94:1355–1360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Christiansen A and Detmar M:
Lymphangiogenesis and cancer. Genes Cancer. 2:1146–1158. 2011.
View Article : Google Scholar
|
|
3
|
Alitalo A and Detmar M: Interaction of
tumor cells and lymphatic vessels in cancer progression. Oncogene.
31:4499–4508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Banerji S, Ni J, Wang SX, Clasper S, Su J,
Tammi R, Jones M and Jackson DG: LYVE-1, a new homologue of the
CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J
Cell Biol. 144:789–801. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Breiteneder-Geleff S, Soleiman A, Kowalski
H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler
E, Alitalo K and Kerjaschki D: Angiosarcomas express mixed
endothelial phenotypes of blood and lymphatic capillaries:
podoplanin as a specific marker for lymphatic endothelium. Am J
Pathol. 154:385–394. 1999. View Article : Google Scholar
|
|
6
|
Mandriota SJ, Jussila L, Jeltsch M,
Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R,
Jackson DG, Orci L, Alitalo K, Christofori G and Pepper MS:
Vascular endothelial growth factor-C-mediated lymphangiogenesis
promotes tumour metastasis. EMBO J. 20:672–682. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stacker SA, Caesar C, Baldwin ME, Thornton
GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H and Achen
MG: VEGF-D promotes the metastatic spread of tumor cells via the
lymphatics. Nat Med. 7:186–191. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Skobe M, Hawighorst T, Jackson DG, Prevo
R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K and Detmar
M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast
cancer metastasis. Nat Med. 7:192–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagy JA, Vasile E, Feng D, Sundberg C,
Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ,
Dvorak AM and Dvorak HF: Vascular permeability factor/vascular
endothelial growth factor induces lymphangiogenesis as well as
angiogenesis. J Exp Med. 196:1497–1506. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirakawa S, Kodama S, Kunstfeld R, Kajiya
K, Brown LF and Detmar M: VEGF-A induces tumor and sentinel lymph
node lymphangiogenesis and promotes lymphatic metastasis. J Exp
Med. 201:1089–1099. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tawada M, Hayashi S, Osada S, Nakashima S
and Yoshida K: Human gastric cancer organizes neighboring lymphatic
vessels via recruitment of bone marrow-derived lymphatic
endothelial progenitor cells. J Gastroenterol. 47:1057–1060. 2012.
View Article : Google Scholar
|
|
12
|
Guadagni F, Witt PL, Robbins PF, Schlom J
and Greiner JW: Regulation of carcinoembryonic antigen expression
in different human colorectal tumor cells by interferon-γ. Cancer
Res. 50:6248–6255. 1990.
|
|
13
|
Imai Y, Leung CK, Friesen HG and Shiu RP:
Epidermal growth factor receptors and effect of epidermal growth
factor on growth of human breast cancer cells in long-term tissue
culture. Cancer Res. 42:4394–4398. 1982.PubMed/NCBI
|
|
14
|
Koshikawa N, Yasumitsu H, Umeda M and
Miyazaki K: Multiple secretion of matrix serine proteinases by
human gastric carcinoma cell lines. Cancer Res. 52:5046–5053.
1992.PubMed/NCBI
|
|
15
|
Hayashi S, Morishita R, Nakamura S,
Yamamoto K, Moriguchi A, Nagano T, Taiji M, Noguchi H, Matsumoto K,
Nakamura T, Higaki J and Ogihara T: Potential role of hepatocyte
growth factor, a novel angiogenic growth factor, in peripheral
arterial disease: downregulation of HGF in response to hypoxia in
vascular cells. Circulation. 100(Suppl 19): II301–II308. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculogenesis in physiological and pathological
neovascularization. Cir Res. 85:221–228. 1999. View Article : Google Scholar
|
|
17
|
Hayashi S, Sato N, Yamamoto A, Ikegame Y,
Nakashima S, Ogihara T and Morishita R: Alzheimer
disease-associated peptide, amyloid β40, inhibits vascular
regeneration with induction of endothelial autophagy. Arterioscler
Thromb Vasc Biol. 29:1909–1915. 2009.
|
|
18
|
Kajiya K, Hirakawa S, Ma B, Drinnenberg I
and Detmar M: Hepatocyte growth factor promotes lymphatic vessel
formation and function. EMBO J. 24:2885–2895. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hogan BM, Bos FL, Bussmann J, Witte M, Chi
NC, Duckers HJ and Schulte-Merker S: ccbe1 is required for
embryonic lymphangiogenesis and venous sprouting. Nat Genet.
41:396–398. 2009. View
Article : Google Scholar
|
|
20
|
Alitalo K: The lymphatic vasculature in
disease. Nat Med. 17:1371–1380. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
He Y, Rajantie I, Ilmonen M, Makinen T,
Karkkainen MJ, Haiko P, Salven P and Alitalo K: Preexisting
lymphatic endothelium but not endothelial progenitor cells are
essential for tumor lymphangiogenesis and lymphatic metastasis.
Cancer Res. 64:3737–3740. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kerjaschki D, Huttary N, Raab I, Regele H,
Bojarski-Nagy K, Bartel G, Kröber SM, Greinix H, Rosenmaier A,
Karlhofer F, Wick N and Mazal PR: Lymphatic endothelial progenitor
cells contribute to de novo lymphangiogenesis in human renal
transplants. Nat Med. 12:230–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maruyama K, Ii M, Cursiefen C, Jackson DG,
Keino H, Tomita M, Van Rooijen N, Takenaka H, D’Amore PA,
Stein-Streilein J, Losordo DW and Streilein JW:
Inflammation-induced lymphangiogenesis in the cornea arises from
CD11b-positive macrophages. J Clin Invest. 115:2363–2372. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Religa P, Cao R, Bjorndahl M, Zhou Z, Zhu
Z and Cao Y: Presence of bone marrow-derived circulating progenitor
endothelial cells in the newly formed lymphatic vessels. Blood.
106:4184–4190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zumsteg A, Baeriswyl V, Imaizumi N,
Schwendener R, Ruegg C and Christofori G: Myeloid cells contribute
to tumor lymphangiogenesis. PLos One. 4:e70672009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferrara N: VEGF and the quest for tumour
angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncl. 23:1011–1027. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lyden D, Hattori K, Dias S, Costa C,
Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y,
Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA,
Manova K, Benezra R and Rafii S: Impaired recruitment of
bone-marrow-derived endothelial and hematopoietic precursor cells
blocks tumor angiogenesis and growth. Nat Med. 7:1194–1201. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wada J, Suzuki H, Fuchino R, Yamasaki A,
Nagai S, Yanai K, Koga K, Nakamura M, Tanaka M, Morisaki T and
Katano M: The contribution of vascular endothelial growth factor to
the induction of regulatory T-cells in malignant effusions.
Anticancer Res. 29:881–888. 2009.PubMed/NCBI
|
|
30
|
Li B, Lalani AS, Harding TC, Luan B,
Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD and Jooss
K: Vascular endothelial growth factor blockade reduces intratumoral
regulatory T cells and enhances the efficacy of a GM-CSF-secreting
cancer immunotherapy. Clin Cancer Res. 12:6808–6816. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gavalas NG, Tsiatas M, Tsitsilonis O,
Politi E, Ioannou K, Ziogas AC, Rodolakis A, Vlahos G, Thomakos N,
Haidopoulos D, Terpos E, Antsaklis A, Dimopoulos MA and Bamias A:
VEGF directly suppresses activation of T cells from ascites
secondary to ovarian cancer via VEGF receptor type 2. Br J Cancer.
107:1869–1875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cursiefen C, Chen L, Borges LP, Jackson D,
Cao J, Radziejewski C, D’Amore PA, Dana MR, Wiegand SJ and
Streilein JW: VEGF-A stimulates lymphangiogenesis and
hemangiogenesis in inflammatory neovascularization via macrophage
recruitment. J Clin Invest. 113:1040–1050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Halin C, Tobler NE, Vigl B, Brown LF and
Detmar M: VEGF-A produced by chronically inflamed tissue induces
lymphangiogenesis in draining lymph nodes. Blood. 110:3158–3167.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kunstfeld R, Hirakawa S, Hong YK, Schacht
V, Lange-Asschenfeldt B, Velasco P, Lin C, Fiebiger E, Wei X, Wu Y,
Hicklin D, Bohlen P and Detmar M: Induction of cutaneous
delayed-type hypersensitivity reactions in VEGF-A transgenic mice
results in chronic skin inflammation associated with persistent
lymphatic hyperplasia. Blood. 104:1048–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hong YK, Lange-Asschenfeldt B, Velasco P,
Hirakawa S, Kunstfeld R, Brown LF, Bohlen P, Senger DR and Detmar
M: VEGF-A promotes tissue repair-associated lymphatic vessel
formation via VEGFR-2 and the α1β1 and α2β1 integrins. FASEB J.
18:1111–1113. 2004.PubMed/NCBI
|
